Stanford Cancer Institute Directory

Translational Oncology Profiles

Showing 21 - 30 of 48
    Professor of Medicine (Oncology) and of Radiology (Molecular Imaging Program at Stanford) at the Stanford University Medical Center
    Assistant Professor of Medicine (Oncology) at the Stanford University Medical Center

    Bio

    Dr. Kunz specializes in the treatment of gastrointestinal malignancies with an expertise in the care of patients with neuroendocrine tumors (NETs). She has developed broad investigative programs in the field of neuroendocrine tumors, encompassing clinical trials, population sciences, and translational correlates. She is the Principal Investigator on numerous clinical trials. She is the Director of the Stanford Neuroendocrine Tumor Program. She currently serves on the National Comprehensive Cancer Network (NCCN) Neuroendocrine Tumors Guidelines Panel, the Neuroendocrine Tumor Taskforce of the National Cancer institute, the NANETS Guidelines and Executive Committees, and leads the NET Working Group of the Eastern Cooperative Oncology Group (ECOG).
    Professor of Biomedical Data Science, Emeritus
    Professor (Research) of Medicine (Oncology)
    Associate Professor (Research) of Radiation Oncology (Radiation and Cancer Biology) and of Radiology (Molecular Imaging Program at Stanford)
    Associate Professor of Medicine (Oncology) at the Stanford University Medical Center

    Bio

    Dr. Massarweh specializes in breast cancer, with a particular interest in Hormone-Receptor Positive and metastatic breast cancer. His research background is in studying endocrine therapy action and resistance mechanisms, as well as ways to overcome it. His outpatient practice is exclusively dedicated to patients with breast cancer and his philosophy is centered around providing his patients with compassionate expert care. Cancer education is an integral part of his academic mission. RESEARCH INTERESTS Endocrine Resistance Triple Positive Breast Cancer Clinical Trial Design CLINICAL INTERESTS: Metastatic Breast Cancer Hormone Receptor Positive Breast Cancer Preoperative Endocrine Therapy Breast Cancer in Pregnant Women Breast Cancer in Men
    Professor of Microbiology and Immunology

    Bio

    For complete and up to date information on this and other items, consult my Curriculum vitae (updated, 12/16), and website; URL: http://www.stanford.edu/~amatin/MatinLabHomePage/MatinLabHome-Page.htm
    The George D. Smith Professor in Translational Medicine
    Associate Professor of Ophthalmology at the Stanford University Medical Center

    Bio

    **DR MRUTHYUNJAYA IS AVAILABLE TO CARE FOR PATIENTS WITH EYE CANCERS AND RETINAL DISEASES** Prithvi Mruthyunjaya MD, MHS is Associate Professor of Ophthalmology at Stanford Univeristy, member of the Vitreoretinal Surgery Service and is the new Director of Ocular Oncology at the Byers Eye Institute. He is a board certified ophthalmologist who has completed two prestigious fellowships: the first in Vitreoretinal Surgery at Duke University and the second in Ocular Oncology at Moorfields Eye Hospital in London, England. He cares for patients with conditions related to cancer of the eye in both adults and children--either benign, pre-cancerous, or eye cancer. These conditions include ocular melanoma, hemangioma, cancers from other parts of the body which spread to the eye, Coats' disease, retinoblastoma, iris tumors (melanoma, cysts, metastatic lesions) and tumors of the conjunctiva including melanoma, and squamous cells carcinoma. He also manages the eye related side effects of chemotherapy treatments. He is an expert in using the most advanced diagnostic tests to make a personalized treatment plan for every patient. With his expertise in retinal surgery, he treats patients with a variety of advanced techniques including small instrument tumor biopsy, vitrectomy, and radiation therapy. As a retinal surgeon, he manages complicated retinal diseases including retinal detachment, macular holes, epiretinal membranes, and diabetic eye disease. His approach to any patient is to provide customized care for every patient and works closely with other experts at the Stanford Cancer Institute. Dr. Mruthyunjaya is actively involved in research in ocular cancer imaging, genetics, and new modalities of tumor biopsy. His passion lies in developing collaborative research networks and training the next generation of vitreoretinal surgeons. His academic contributions were recognized by the Heed, AOS-Knapp and Ronald G Michels foundations the American Society of Retina Specialists with a Senior Honor Award. He was recently listed as one of the worlds 150 most innovative retinal specialists. BIOGRAPHY: Dr. Mruthyunjaya was born in India and moved to Upstate New York at the age of 2. He was selected for the highly prestigious accelerated 6-year medical program completing his undergraduate studies at Rensselaer in 2 years then moving on to complete his medical studies at Albany Medical College where he was elected to the Alpha Omega Alpha honor society. At the Duke Eye Center in Durham, NC, he finished his Ophthalmology residency, Chief Residency, and clinical-research fellowships in Vitreoretinal surgery followed by an Ocular Oncology fellowship at the Moorfields Eye Hosptial in London, UK. As a fellow, he was recognized with the highest nationwide honors by the Heed, AOS-Knapp and Ronald G Michels foundations. He was on faculty at Duke from 2005-16 where developed an integrated Retina-Ocular Oncology program and was named a tenured Associate Professor of Ophthalmology and Radiation Oncology, Medical Director and Director of Ocular Oncology. He has enjoyed moving to the Bay area with his family.
    Assistant Professor of Medicine (Oncology) at the Stanford University Medical Center

    Bio

    Dr. Neal holds a medical degree and a doctoral degree in Tumor Cell Biology from Northwestern University in Chicago, Illinois. Subsequently, he completed a fellowship in oncology, rotating through the Dana-Farber Cancer Institute and Massachusetts General Hospital in Boston, Massachusetts. He is currently an Assistant Professor in the Division of Oncology at the Stanford Cancer Institute at Stanford University in Palo Alto, California. Dr Neal’s primary clinical interest is in thoracic oncology. In addition to maintaining an active practice, he focuses on the design and conduct of clinical trials involving targeted therapies and immunotherapy for lung cancer and mesothelioma. He has published dozens of articles in the field of thoracic oncology, including in Lancet Oncology, Nature Medicine, and the Journal of Clinical Oncology. He is a member of the International Association of the Study of Lung Cancer (IALSC), is a study chair and thoracic core committee member within the ECOG-ACRIN cooperative group, and has presented at a number of American Society of Clinical Oncology (ASCO) annual meetings.

Affiliations

Organizations